Life Sciences And Medical Technology Payment Trends: 2022 vs 2023
Flatline: Payment Practices in Life Sciences and MedTech Stuck at 59.8/100 Between 2022 and 2023
The Comparison
- 2022: A review of 109 Life Sciences and Medical Technology companies yielded an average payment practices score of 59.8 out of 100.
- 2023: Analysis of 118 firms in the same sectors showed an identical average score of 59.8 out of 100.
What This Means
Despite an increase in the sample size (9 additional companies reviewed in 2023), payment practices within the Life Sciences and MedTech sectors remained virtually unchanged year-on-year, suggesting that systemic improvements in payment behaviour are not occurring. This lack of movement highlights persistent challenges, even with a broader range of companies included in the assessment.
Payment practices in the Life Sciences and Medical Technology sectors show no significant improvement, remaining static at 59.8/100 despite reviewing more companies. You can use this late payment calculator to work out interest and compensation owed.
